World Prematurity Day

Argentina, Australia, Austria, Belgium, Brazil, Canada, Chile, China, Colombia, Croatia, Czech Republic, Denmark, Ecuador, Egypt, Finland, France, Germany, Greece, India, Indonesia, Ireland, Israel, Italy, Japan, Kenya, Malaysia, Mexico, Netherlands, New Zealand, Nigeria, Norway, Pakistan, Peru, Philippines, Poland, Portugal, Romania, Saudi Arabia, Singapore, South Africa, South Korea, Spain, Sweden, Switzerland, Thailand, Turkey, Uganda, United Arab Emirates, United Kingdom, United States, Vietnam

About

World Prematurity Day, observed on November 17, raises awareness of babies who are born too soon and the challenges they, their families, and their caregivers may face. It is a time to recognize the strength of premature infants, honor the dedication of neonatal care teams, and highlight the importance of compassionate, specialized support from the earliest moments of life.

The observance also encourages conversations about preventing preterm births and improving care for babies and parents around the world. By sharing stories, learning more about prematurity, and showing support for affected families, people can help build greater understanding and hope for healthier beginnings.

History

World Prematurity Day is observed annually on **November 17** to draw attention to babies born before 37 completed weeks of pregnancy and to the health, social, and emotional needs of their families. Its origins lie in the work of the European Foundation for the Care of Newborn Infants (EFCNI), established in 2008 to represent premature infants and their parents and to promote improvements in neonatal care. EFCNI and parent organizations in Europe helped establish the observance, which was initially known in some settings as International Preemie Day.

The observance gained wider international support through cooperation among parent groups, hospitals, professional organizations, and advocacy bodies, including March of Dimes, LittleBigSouls, and the National Premmie Foundation. November 17 became associated with the movement as a day for sharing information about premature birth, honoring the resilience of infants and families, and recognizing the work of neonatal-care professionals. Over time, participation expanded beyond Europe, turning the day into a global public-awareness campaign.

As World Prematurity Day evolved, its focus broadened from celebrating premature infants to addressing the conditions that influence survival and long-term well-being. Campaigns now commonly emphasize access to skilled prenatal and obstetric care, specialized neonatal services, family involvement in treatment, breastfeeding and kangaroo care where appropriate, and continuing medical and developmental support after discharge. These priorities are especially significant in regions where preventable complications, limited resources, and unequal access to healthcare contribute to premature deaths and disability.

Culturally, the day provides a shared occasion for families to tell their stories and for communities to express solidarity with parents whose children require neonatal intensive care. Hospitals and advocacy groups may mark **November 17** with educational programs, remembrance activities, symbolic displays, and public campaigns intended to reduce stigma and make prematurity more visible. The observance also connects personal experiences with a broader global health concern: according to international health agencies, preterm birth remains a major cause of death among children under five, making World Prematurity Day both a tribute to affected families and a call for stronger maternal and newborn care.

Timeline

1952
Dr. Virginia Apgar introduced the Apgar score, a rapid five-part assessment of a newborn’s condition that became a standard tool for evaluating babies immediately after birth, including premature infants.
1971
George A. Gregory and colleagues reported using continuous positive airway pressure (CPAP) to treat neonatal respiratory distress syndrome, an important advance for premature infants with underdeveloped lungs.
1990
The U.S. Food and Drug Administration approved Exosurf Neonatal, a synthetic surfactant therapy for respiratory distress syndrome in premature babies.

Upcoming dates

Sources

Same day

Related